MUHS publishes Notice of Finalization of Seating Matrix Table for Dental Schools for 2023-2024.

Published Date: 06 Mar 2023

Maharashtra: The Maharashtra University of Health Sciences (MUHS) has issued the notification of completion of the matrix list of seats by the course for:

Read Full News

Latest News



Todays Updates


LEVI-04 Improves Pain, Function in Knee Osteoarthritis, with Philip Conaghan, MBBS, PhD Philip Conaghan, MBBS, PhD


Conaghan discussed the potential of LEVI-04 for knee osteoarthritis at ACR 2025.

Alzheimer Trial PRImus-AD Tests Orally Available PRI-002 as New Treatment Louie Pasculli


The adaptive PRImus-AD phase 2a trial will evaluate the safety and efficacy of PRI-002, a novel investigational agent, in patients with mild cognitive impairment or mild Alzheimer disease.

CTAD Poster Shows Etalanetug Reduced Tau Pathology Biomarkers in Dominantly Inherited Alzheimer Disease Isabella Ciccone, MPH


Treatment with etalanetug reduced cerebrospinal fluid eMTBR-tau243 by 62% and plasma eMTBR-tau243 by 78% at 3 months in patients with dominantly inherited Alzheimer disease.

Alzheimer Vaccine ABvac40 Results in Lowered Cortical Perfusion Decline Marco Meglio


A recent study reveals that Araclon's ABvac40 vaccine may slow cortical perfusion decline in patients with Alzheimer disease, suggesting potential cognitive benefits.

Difficult Cases and Red Flags in Dermatology, With Kassandra Holzem, MD Kassandra Holzem, MD


In her SDPA Fall Dermatology Conference interview, Holzem highlights key warning signs for a variety of dermatologic conditions requiring hospital admission.

Firsekibart Beats Colchicine as Gout Flare Prophylaxis When Initiating ULT


Firsekibart Beats Colchicine as Gout Flare Prophylaxis When Initiating ULT

Deep Capillary Plexus Microaneurysms A Sign of CKD in Diabetic Retinopathy


Deep Capillary Plexus Microaneurysms A Sign of CKD in Diabetic Retinopathy

Todays Updates


LEVI-04 Improves Pain, Function in Knee Osteoarthritis, with Philip Conaghan, MBBS, PhD Philip Conaghan, MBBS, PhD


Conaghan discussed the potential of LEVI-04 for knee osteoarthritis at ACR 2025.

Alzheimer Trial PRImus-AD Tests Orally Available PRI-002 as New Treatment Louie Pasculli


The adaptive PRImus-AD phase 2a trial will evaluate the safety and efficacy of PRI-002, a novel investigational agent, in patients with mild cognitive impairment or mild Alzheimer disease.

CTAD Poster Shows Etalanetug Reduced Tau Pathology Biomarkers in Dominantly Inherited Alzheimer Disease Isabella Ciccone, MPH


Treatment with etalanetug reduced cerebrospinal fluid eMTBR-tau243 by 62% and plasma eMTBR-tau243 by 78% at 3 months in patients with dominantly inherited Alzheimer disease.

Alzheimer Vaccine ABvac40 Results in Lowered Cortical Perfusion Decline Marco Meglio


A recent study reveals that Araclon's ABvac40 vaccine may slow cortical perfusion decline in patients with Alzheimer disease, suggesting potential cognitive benefits.

Difficult Cases and Red Flags in Dermatology, With Kassandra Holzem, MD Kassandra Holzem, MD


In her SDPA Fall Dermatology Conference interview, Holzem highlights key warning signs for a variety of dermatologic conditions requiring hospital admission.

Firsekibart Beats Colchicine as Gout Flare Prophylaxis When Initiating ULT


Firsekibart Beats Colchicine as Gout Flare Prophylaxis When Initiating ULT

Deep Capillary Plexus Microaneurysms A Sign of CKD in Diabetic Retinopathy


Deep Capillary Plexus Microaneurysms A Sign of CKD in Diabetic Retinopathy

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma

2.

'Next Berlin Patient' Adds to Small but Growing Number of People Cured of HIV

3.

Cancer diagnosis does not spur improvements to survivors' diets or eating habits

4.

Two medications might work better for breast cancers that are resistant to one.

5.

Doctor Suspected of Murder; Cancer Blood Test Under Fire; TikTok and Body Image


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot